JENNIFER COCHRAN, PH.D

Corporate Board Profile

Tech Score: 0/100

LIGAND PHARMACEUTICALS INC

Filing Date	Source Excerpt
2022-04-22	Jennifer Cochran, Ph.D. has served on our board of directors since July 2021. Dr. Cochran is a Professor of Bioengineering at Stanford University and Chief Scientific Advisor to Red Tree Venture Capital. Dr. Cochran’s extensive bioengineering background and knowledge of the biopharmaceutical industry contributed to our board of directors’ conclusion that she should serve as a director of our company. Total compensation for 2021 was $460,479.

Filing Date

Source Excerpt

2022-04-22

Jennifer Cochran, Ph.D. has served on our board of directors since July 2021. Dr. Cochran is a Professor of Bioengineering at Stanford University and Chief Scientific Advisor to Red Tree Venture Capital. Dr. Cochran’s extensive bioengineering background and knowledge of the biopharmaceutical industry contributed to our board of directors’ conclusion that she should serve as a director of our company. Total compensation for 2021 was $460,479.

Data sourced from SEC filings. Last updated: 2026-02-03